Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer.

Area of Science:

• Respiratory Medicine
• Biomarker Discovery
• Analytical Chemistry

Background:

• Persistent asthma exhibits diverse inflammatory phenotypes, including eosinophilic, neutrophilic, and paucigranulocytic.
• Accurate phenotyping is crucial for targeted asthma management.
• Volatile organic compound (VOC) analysis of exhaled breath presents a novel diagnostic approach.

Purpose of the Study:

• To evaluate the efficacy of electronic nose technology in differentiating between inflammatory asthma phenotypes.
• To assess the capability of volatile organic compound (VOC) breath-prints to distinguish eosinophilic, neutrophilic, and paucigranulocytic asthma.

Main Methods:

• A cross-sectional study included 52 patients with persistent asthma.
• Inflammatory phenotypes were determined using induced sputum cell counts.
• Electronic nose (Cyranose 320) analyzed volatile organic compound (VOC) breath-prints, with discriminant analysis and receiver operating characteristic (ROC) curves used for assessment.

Main Results:

• The electronic nose accurately differentiated between eosinophilic and neutrophilic asthma (73% accuracy, AUC 0.92).
• Eosinophilic asthma was also distinguished from paucigranulocytic asthma (74% accuracy, AUC 0.79).
• Neutrophilic and paucigranulocytic phenotypes were differentiated with 89% accuracy (AUC 0.88).

Conclusions:

• Electronic nose analysis of volatile organic compound (VOC) breath-prints can effectively discriminate between inflammatory asthma phenotypes.
• This technology shows potential for routine clinical application in asthma phenotyping.
• The study confirms the electronic nose as a valuable tool for non-invasive asthma classification.